Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine When Co-Administered with Tetanus-Reduced Diphtheria-Acellular Pertussis and Quadrivalent Meningococcal Conjugate Vaccines in Healthy Adolescents: Results from a Randomized, Observer-Blind, Controlled Trial
ConclusionOverall, these data support the concomitant administration of HPV4, Tdap and MenACWY-CRM in adolescents.FundingNovartis Vaccines and Diagnostics Inc., now part of the GSK group of companies.Trial RegistrationClinicalTrials.gov identifier, NCT01424644.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Cervical Cancer Vaccine | Diphtheria | Eyes | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Infectious Diseases | Men | Meningitis | Meningitis Vaccine | Study | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Vaccines | Whooping Cough (Pertussis) Vaccine